Ophthalmology is a branch of medicine that deals with the anatomy, physiology, and diseases of the eye.
In 2017, the global Opthalmology Drugs and Devices market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2018-2025.
This report focuses on the global Opthalmology Drugs and Devices status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Opthalmology Drugs and Devices development in United States, Europe and China.
The key players covered in this study
Merck (US)
Pfizer (US)
Roche Holdings (Switzerland)
Santen Pharmaceutical(Japan)
Abbott Medical Optics (US)
Alcon (Switzerland)
Bausch & Lomb (US)
Carl Zeiss Meditec (Germany)
Essilor International S.A. (France)
Johnson & Johnson (US)
Nidek(Japan)
Topcon Corporation (Japan)
Market segment by Type, the product can be split into
Device
Drug
Market segment by Application, split into
Hosptial
Clinic
Others
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Opthalmology Drugs and Devices status, future forecast, growth opportunity, key market and key players.
To present the Opthalmology Drugs and Devices development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Opthalmology Drugs and Devices are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025
For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.